Flagship Harbor Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $524K | Sell |
4,147
-251
| -6% | -$33.1K | 0.02% | 508 |
|
|
2026
Q1 | $613K | Buy |
4,398
+1,316
| +43% | +$184K | 0.03% | 427 |
|
|
2025
Q4 | $378K | Sell |
3,082
-1,927
| -38% | -$234K | 0.02% | 503 |
|
|
2025
Q3 | $556K | Buy |
5,009
+429
| +9% | +$48.8K | 0.02% | 469 |
|
|
2025
Q2 | $508K | Buy |
4,580
+184
| +4% | +$19.6K | 0.02% | 468 |
|
|
2025
Q1 | $493K | Buy |
4,396
+193
| +5% | +$19.9K | 0.03% | 437 |
|
|
2024
Q4 | $388K | Sell |
4,203
-83
| -2% | -$7.47K | 0.02% | 494 |
|
|
2024
Q3 | $359K | Sell |
4,286
-960
| -18% | -$73.3K | 0.02% | 500 |
|
|
2024
Q2 | $360K | Sell |
5,246
-413
| -7% | -$27.6K | 0.02% | 491 |
|
|
2024
Q1 | $415K | Sell |
5,659
-2
| -0% | -$154 | 0.03% | 432 |
|
|
2023
Q4 | $459K | Sell |
5,661
-235
| -4% | -$18.3K | 0.03% | 381 |
|
|
2023
Q3 | $442K | Sell |
5,896
-54
| -0.9% | -$4.15K | 0.04% | 363 |
|
|
2023
Q2 | $459K | Sell |
5,950
-692
| -10% | -$55.2K | 0.04% | 359 |
|
|
2023
Q1 | $551K | Buy |
6,642
+684
| +11% | +$56.7K | 0.05% | 334 |
|
|
2022
Q4 | $511K | Sell |
5,958
-344
| -5% | -$27.2K | 0.05% | 329 |
|
|
2022
Q3 | $389K | Buy |
6,302
+1,274
| +25% | +$80.3K | 0.05% | 366 |
|
|
2022
Q2 | $311K | Buy |
5,028
+1,230
| +32% | +$76.2K | 0.03% | 447 |
|
|
2022
Q1 | $226K | Sell |
3,798
-798
| -17% | -$51K | 0.02% | 563 |
|
|
2021
Q4 | $334K | Sell |
4,596
-84
| -2% | -$5.79K | 0.03% | 468 |
|
|
2021
Q3 | $322K | Hold |
4,680
| – | – | 0.03% | 467 |
|
|
2021
Q2 | $322K | Buy |
4,680
+205
| +5% | +$13.7K | 0.03% | 468 |
|
|
2021
Q1 | $289K | Sell |
4,475
-3,066
| -41% | -$198K | 0.03% | 484 |
|
|
2020
Q4 | $439K | Sell |
7,541
-769
| -9% | -$46.4K | 0.05% | 338 |
|
|
2020
Q3 | $525K | Sell |
8,310
-2,688
| -24% | -$186K | 0.07% | 248 |
|
|
2020
Q2 | $846K | Buy |
10,998
+529
| +5% | +$40.5K | 0.12% | 163 |
|
|
2020
Q1 | $783K | Buy |
10,469
+2,382
| +29% | +$165K | 0.16% | 136 |
|
|
2019
Q4 | $526K | Sell |
8,087
-60
| -0.7% | -$3.91K | 0.09% | 219 |
|
|
2019
Q3 | $516K | Buy |
8,147
+266
| +3% | +$17.4K | 0.1% | 202 |
|
|
2019
Q2 | $532K | Buy |
7,881
+78
| +1% | +$5.13K | 0.11% | 188 |
|
|
2019
Q1 | $507K | Sell |
7,803
-308
| -4% | -$20.5K | 0.1% | 212 |
|
|
2018
Q4 | $507K | Buy |
8,111
+1,186
| +17% | +$82.9K | 0.12% | 183 |
|
|
2018
Q3 | $540K | Sell |
6,925
-115
| -2% | -$8.69K | 0.1% | 218 |
|
|
2018
Q2 | $498K | Sell |
7,040
-522
| -7% | -$36.9K | 0.1% | 217 |
|
|
2018
Q1 | $550K | Sell |
7,562
-340
| -4% | -$27K | 0.16% | 156 |
|
|
2017
Q4 | $581K | Sell |
7,902
-850
| -10% | -$64.5K | 0.17% | 147 |
|
|
2017
Q3 | $713K | Sell |
8,752
-750
| -8% | -$57.4K | 0.23% | 115 |
|
|
2017
Q2 | $656K | Buy |
9,502
+335
| +4% | +$22.3K | 0.23% | 122 |
|
|
2017
Q1 | $610K | Sell |
9,167
-309
| -3% | -$21.7K | 0.23% | 125 |
|
|
2016
Q4 | $673K | Buy |
+9,476
| New | +$704K | 0.29% | 98 |
|
Other funds holding GILD
Flagship Harbor Advisors's GILD Position: Q2 2026 in Review
Flagship Harbor Advisors reduced its Gilead Sciences (GILD) stake by 5.7% in Q2 2026, selling an estimated $33.1K and leaving 4,147 shares worth $524K. The position accounts for 0.02% of the portfolio, ranked #508.
Flagship Harbor Advisors first reported a position in GILD in Q4 2016 and has held it in 39 quarters since. The position peaked at $846K in Q2 2020. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Flagship Harbor Advisors held 4,147 shares of Gilead Sciences worth $524K as of Q2 2026.
- Flagship Harbor Advisors sold 251 Gilead Sciences shares in Q2 2026, an estimated $33.1K.
- Gilead Sciences made up 0.02% of Flagship Harbor Advisors's portfolio in Q2 2026, its #508 holding.
- Flagship Harbor Advisors first reported a position in Gilead Sciences in Q4 2016 and has held it in 39 quarters since.
- Flagship Harbor Advisors's Gilead Sciences position peaked at $846K in Q2 2020.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Flagship Harbor Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.